A multiparametric study of the action of mifepristone used in emergency contraception using the rhesus monkey as a primate model

Contraception

Volumn 68, Issue 6, 2003, Pages 453-469

  Sengupta, Jayasree ^a   Dhawan, Latika ^a   Lalitkumar, P G L ^a   Ghosh, D ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Cytokines; Endometrium; Immunohistochemistry; Mifepristone; Morphology; Rhesus monkey

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLINE; ESTRADIOL; ESTRADIOL RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MIFEPRISTONE; PLACENTA PROTEIN 14; PROGESTERONE; PROGESTERONE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; BLOOD SAMPLING; COITUS; CONFERENCE PAPER; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMERGENCY CONTRACEPTION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MALE; MITOSIS INDEX; NICK END LABELING; NIDATION; NONHUMAN; OVARY FUNCTION; OVULATION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RHESUS MONKEY; SINGLE DRUG DOSE; TISSUE DEGENERATION;

EID: 1642539005     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00108-2     Document Type: Conference Paper

References (75)

1. Van Look P.F., Von Hertzen H. Emergency contraception. Br Med Bull. 49:1993;158-170.
2. Bartfai G. Emergency contraception in clinical practice global perspectives . Int J Gyncol Obstet. 70:2000;49-58.
3. Wellbery C. Emergency contraception. Arch Fam Med. 9:2000;642-646.
4. Van Look P.F., Von Hertzen H. Post-ovulatory methods of fertility regulation: the emergence of antiprogestogens. Van Look P.F.A., Perez-Palacios G. Contraceptive research and development. 1994;1984-1994 Oxford University Press, New Delhi.
5. Webb A.M. Intrauterine contraceptive devices and antigestagens as emergency contraception. Eur J Reprod Health Care. 2:1997;243-246.
6. Glasier A. Safety of emergency contraception. J Am Med Women Assoc. 53:1998;219-221.
7. Harrison P.F., Rosenfield A. Contraceptive research and development - looking to the future. 1996;National Academy Press, Washington (DC).
8. Ho P.C. Emergency contraception methods and efficacy . Curr Opin Obstet Gynecol. 12:2000;175-179.
9. Glasier A., Thong K.J., Dewar M., Mackie M., Baird D.T. Postcoital contraception with mifepristone. Lancet. 337:1991;1414-1415.
10. Glasier A., Thong K.J., Dewar M., Mackie M., Baird D.T. Mifepristone (RU486) compared with high-dose estrogen, and progesterone for emergency contraception. N Engl J Med. 327:1992;1041-1044.
11. Webb A.M., Russell J., Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. Br Med J. 305:1992;927-931.
12. Schein A.B. Pregnancy prevention using emergency contraception efficacy, attitudes and limitation to use . J Pediatr Adolesc Gynecol. 12:1999;3-9.
13. Comparison of three doses of mifepristone as emergency contraception a randomized trial . Lancet. 353:1999;697-702.
14. Spitz I.M., Van Look P.F., Coelingh Bennink H.J. The use of progesterone antagonists and progesterone receptor modulators in contraception. Steroids. 65:2000;817-823.
15. Croxatto H.B., Devoto L., Durand M., et al. Mechanism of action of hormonal preparations used for emergency contraception. A review of the literature. Contraception. 63:2001;111-121.
16. Ghosh D., Sengupta J. Patterns of estrogen and progesterone receptors in rhesus monkey endometrium during the secretory phase of normal menstrual cycle and preimplantation stages of gestation. J Steroid Biochem. 31:1988;223-229.
17. Ghosh D., Sengupta J. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey. Hum Reprod. 8:1993;552-558.
18. Ghosh D., Sengupta J., Hendrickx A.G. Effect of a single-dose, early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey. Hum Reprod. 11:1996;2026-2035.
19. Ghosh D., Stewart D.R., Nayak N.R., et al. Serum concentrations of estradiol-17β, progesterone, relaxin and chorionic gonadotrophin during blastocyst implantation in natural pregnancy cycle and in embryo transfer cycle in the rhesus monkey. Hum Reprod. 12:1997;914-920.
20. Ghosh D., Nayak N.R., Sengupta J. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey. Contraception. 56:1997;117-122.
21. Ghosh D., Roy A., Sengupta J., Johannisson E. Morphological characteristics of preimplantation stage endometrium in the rhesus monkey. Hum Reprod. 8:1993;1579-1587.
22. Ghosh D., Lalitkumar P.G., Wong V., et al. Effect of vaginally administered fumagillin on the morphology of implantation stage endometrium in the rhesus monkey. Contraception. 63:2001;95-102.
23. Szekeres G., Lutz Y., Tourneau A.L., Delage M. Steroid hormone receptor immunostaining on paraffin sections with microwave heating and trypsin digestion. J Histotechnol. 17:1994;321-327.
24. Nayak N.R., Ghosh D., Sengupta J. Effects of luteal phase administration of mifepristone (RU486) and prostaglandin analogue or inhibitor on endometrium in the rhesus monkey. Hum Reprod. 13:1998;1047-1056.
25. Ghosh D., Dhara S., Kumar A.K., Sengupta J. Immunohistochemical localization of receptors for progesterone and estradiol-17β in the implantation site of the Rhesus monkey. Hum Reprod. 14:1999;505-514.
26. Ghosh D., Kumar P.G.L.L., Sengupta J. Effects of early luteal phase administration of mifepristone (RU486) on leukeamia inhibitory factor, transforming growth factor β and vascular endothelial growth factor in the implantation stage endometrium in the rhesus monkey. J Endocrinol. 157:1998;115-125.
27. Lalitkumar P.G.L., Sengupta J., Karande A., Ghosh D. Placental protein 14 in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium in the rhesus monkey. Hum Reprod. 13:1998;3478-3486.
28. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
29. Press M.F., Udove J.A., Green G.L. Progesterone receptor distribution in human endometrium. Am J Pathol. 131:1988;121-124.
30. Steel R.G.D., Torrie J.H. Principles and procedures of statistic - a biomedical approach. 1980;Kogakusha Ltd., Japan McGraw-Hill, Tokyo.
31. Ghosh D., De P., Sengupta J. Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey. Indian J Physiol Pharmacol. 37:1993;13-18.
32. Ghosh D., Kumar P.G.L., Sengupta J. Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey. Hum Reprod. 12:1997;575-582.
33. Ghosh D., De P., Sengupta J. Luteal phase oestrogen is not essential for implantation and maintenance of pregnancy from surrogate embryo transfer in the rhesus monkey. Hum Reprod. 9:1994;629-637.
34. Ghosh D., Sengupta J. Endometrial receptivity for implantation. Another look at the issue of preimplantation oestrogen. Hum Reprod. 10:1995;1-2.
35. Zegers-Hochschild F., Altieri E. Luteal phase estrogen is not required for the establishment of pregnancy in the human. J Assist Reprod Genet. 12:1995;224-228.
36. Edwards R.G. Implantation, interception and contraception. Hum Reprod. 9:1994;985-995.
37. Sengupta J., Ghosh D. Role of progesterone on peri-implantation stage endometrium-embryo interaction in the primate. Steroids. 65:2000;753-762.
38. Tabibzadeh S., Babaknia A. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod. 10:1995;1579-1602.
39. Ghosh D., Sengupta J. Recent developments in endocrinology and paracrinology of blastocyst implantation in the primate. Hum Reprod Update. 4:1998;153-168.
40. Hill J.A. Maternal-embryonic cross-talk. Ann NY Acad Sci. 943:2001;17-25.
41. Simon C., Gimeno M.J., Mercader A., et al. Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro. J Clin Endocrinol Metab. 82:1997;2607-2616.
42. Simon C., Moreno C., Remohi J., Pellicer A. Cytokines and embryo implantation. J Reprod Immunol. 39:1998;117-131.
43. Li T.C., Dockery P., Thomas P., Rogers A.W., Lenton E.A., Cooke I.D. The effects of progesterone receptor blockade in the luteal phase of normal fertile women. Fertil Steril. 50:1988;732-742.
44. Graham R.A., Li T.C., Seif M.W., Aplin J.D., Cooke I.D. The effects of the antiprogesterone RU486 (mifepristone) on an endometrial secretory glycan an immunocytochemical study . Fertil Steril. 55:1991;1132-1136.
45. Berthois Y., Salat-Baroux J., Cornet D., De Brux J., Kopp F., Martin P.M. A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil Steril. 55:1991;547-554.
46. Cameron S.T., Critchley H.O., Thong K.J., Buckley C.H., Williams A.R., Baird D.T. Effect of low dose mifepristone on endometrial maturation and proliferation. Hum Reprod. 11:1996;2518-2526.
47. Chillik C.F., Hsiu J.G., Acosta A.A., van Uem J.F., Hodgen G.D. RU486-induced menses in cynomolgus monkeys uniformity of endometrial sloughing . Fertil Steril. 45:1986;708-712.
48. Rotello R.J., Lieberman R.C., Lepoff R.B., Gerschenson L.E. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am J Pathol. 140:1992;449-456.
49. Koshiyama M., Konishi I., Nanbu K., et al. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium correlation with sex steroid receptors and Ki-67 antigen expression . J Clin Endocrinol Metab. 80:1995;1106-1112.
50. Malumbres M., Barbacid M. To cycle or not cycle a critical decision in cancer . Nat Rev Cancer. 1:2001;222-231.
51. Cameron S.T., Critchley H.O., Buckley C.H., Kelly R.W., Baird D.T. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril. 67:1997;1046-1053.
52. Kumar S., Zhu L.J., Polihronis M., et al. Progesterone induces calcitonin gene expression in human endometrium within the putative window of implantation. Clin Endocrinol Metab. 83:1998;4443-4450.
53. Critchley H.O., Tong S., Cameron S.T., Drudy T.A., Kelly R.W., Baird D.T. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J Reprod Fertil. 115:1999;389-395.
54. Prelich G., Tan C.K., Kostura M., et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature. 326:1987;517-520.
55. Heikinheimo O., Hsiu J.G., Gordon K., et al. Endometrial effects of RU486 in primates. Antiproliferative action despite signs of estrogen action and increased cyclin B expression. Steroid Biochem Mol Biol. 59:1996;179-190.
56. Slayden O.D., Zelinski-Wooten M.B., Chwalisz K., Stouffer R.L., Brenner R.M. Chronic treatment of cycling rhesus monkeys with low doses of antiporgestin ZK137316 morphometric assessment of the uterus and oviduct . Hum Reprod. 13:1998;269-277.
57. Brenner R.M., Maslar I.A. The primate oviduct and endometrium. Knobil E., Neill J.D. The physiology of reproduction. 1988;303-329 Raven Press, New York.
58. Johannisson E. Morphological and histochemical factors related to implantation. Baillieres Clin Obstet Gynaecol. 5:1991;191-209.
59. Mazur M.T., Duncan D.A., Benjamin Younger J. Endometrial biopsy in the cycle of conception histologic and lectin histochemical evaluation . Fertil Steril. 51:1989;764-769.
60. King R.J.B., d'Arcangues C. Steroid hormone effects on uterine blood vessels. Alexander N.J., d'Arcangues C. Steroid hormones and uterine bleeding. 1992;25-36 AAAS Press, Washington (DC).
61. Horwitz K.B., Horwitz L.D. Canine vascular tissue are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest. 69:1982;750-758.
62. Perrot-Applanat M., Groyer-Picard M.L., Garcia E., Lorenzo F., Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology. 123:1988;1511-1519.
63. Critchley H.O., Brenner R.M., Henderson T.A., et al. Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 86:2001;1370-1378.
64. Johannisson E., Oberholzer M., Swahn M.L., Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU486. Contraception. 39:1989;103-117.
65. Ghosh D., De P., Sengupta J. Effect of RU486 on the endometrial response to deciduogenic stimulus in ovariectomized rhesus monkeys treated with oestrogen and progesterone. Hum Reprod. 7:1992;1048-1060.
66. Ace C.I., Okulicz W.C. Identification of progesterone-dependent messenger ribonucleic acid regulatory patterns in the rhesus monkey endometrium by differential-display reverse transcription-polymerase chain reaction. Biol Reprod. 60:1999;1029-1035.
67. Greb R.R., Bukowski R., Hsiu J.G., et al. Vascular endothelial growth factor (VEGF) in primate endometrium. Immunohistochemical patterns during the cycle and after chronic RU486 treatment in cynomolgus monkeys. Ann NY Acad Sci. 761:1995;376-382.
68. Greb R.R., Heikinheimo O., Williams R.F., et al. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. Hum Reprod. 12:1997;1280-1292.
69. Baulieu E.E. Contragestion and other clinical applications of RU48, an antiprogesterone, at the receptor. Science. 245:1989;1351-1357.
70. Jaffe E.A. Physiologic function of normal endothelial cells. Loscatzo J., Craeger M.A., Dzau V.J. Vascular medicine. 1992;3-46 Little Brown and Co, Boston.
71. Ghosh D., De P., Sengupta J. Luteal phase contraception with mifepristone (RU486) in the rhesus monkey. Ind J Physiol Pharmacol. 38:1994;17-22.
72. Swahn M.L., Bygdeman M., Cekan S., Xing S., Masironi B., Johannisson E. The effect of RU486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum Reprod. 5:1990;402-408.
73. Cameron S.T., Critchley H.O., Buckley C.H., Chard T., Kelly R.W., Baird D.T. The effects of post-ovulatory administration of onapristone on development of a secretory endometrium. Hum Reprod. 11:1996;40-49.
74. Gemzell-Danielsson K., Svalander P., Swahn M.L., Johannisson E., Bygdeman M. Effects of a single-postovulatory dose of RU486 on endometrial maturation in the implantation phase. Hum Reprod. 9:1994;2398-2404.
75. Gemzell-Danielson K., Swahn M.L., Bygdeman M. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase - an immunohistochemical study. Hum Reprod. 12:1997;1293-1297.